A. Bakker

Publications11
h-index10
Citations1,660
Highly Influential Citations174
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • C. Rupprecht
  • 555 Publications, 25,311 Citations
  • A. Bakker
  • 509 Publications, 85,354 Citations
  • B. Dietzschold
  • 252 Publications, 13,980 Citations
  • H. Koprowski
  • 758 Publications, 41,756 Citations
  • Publications
  • Influence
Development and validation of the job crafting scale
We developed and validated a scale to measure job crafting behavior in three separate studies conducted in The Netherlands (totalN = 1181). Job crafting is defined as the self-initiated changes that… Expand
  • 653
  • 132
  • PDF
C-Type Lectin-Like Molecule-1
Acute myeloid leukemia (AML) has a poor prognosis due to treatment-resistant relapses. A humanized anti-CD33 antibody (Mylotarg) showed a limited response rate in relapsed AML. To discover novel AML… Expand
  • 132
  • 12
  • PDF
Novel Human Monoclonal Antibody Combination Effectively Neutralizing Natural Rabies Virus Variants and Individual In Vitro Escape Mutants
ABSTRACT The need to replace rabies immune globulin (RIG) as an essential component of rabies postexposure prophylaxis is widely acknowledged. We set out to discover a unique combination of human… Expand
  • 114
  • 10
  • PDF
Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets
Summary SARS coronavirus continues to cause sporadic cases of severe acute respiratory syndrome (SARS) in China. No active or passive immunoprophylaxis for disease induced by SARS coronavirus is… Expand
  • 229
  • 6
  • PDF
Molecular and Biological Characterization of Human Monoclonal Antibodies Binding to the Spike and Nucleocapsid Proteins of Severe Acute Respiratory Syndrome Coronavirus
ABSTRACT Human monoclonal antibodies (MAbs) were selected from semisynthetic antibody phage display libraries by using whole irradiated severe acute respiratory syndrome (SARS) coronavirus (CoV)… Expand
  • 107
  • 5
  • PDF
Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin.
The World Health Organization estimates human mortality from endemic canine rabies to be 55,000 deaths/year. Limited supply hampers the accessibility of appropriate lifesaving treatment, particularly… Expand
  • 87
  • 3
  • PDF
A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis.
The currently recommended treatment for individuals exposed to rabies virus is the combined administration of rabies vaccine and rabies immune globulin (RIG). This review sets out the criteria used… Expand
  • 66
  • 2
Novel Rabies Virus-Neutralizing Epitope Recognized by Human Monoclonal Antibody: Fine Mapping and Escape Mutant Analysis
ABSTRACT Anti-rabies virus immunoglobulin combined with rabies vaccine protects humans from lethal rabies infections. For cost and safety reasons, replacement of the human or equine polyclonal… Expand
  • 69
  • 2
Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro.
MHC class I-restricted CTLs specific for antigens expressed by malignant cells are an important component of immune responses against human cancer. Recently, in melanoma a number of melanocyte… Expand
  • 179
  • 1
  • PDF
Validation of the Rapid Fluorescent Focus Inhibition Test for Rabies Virus-Neutralizing Antibodies in Clinical Samples
ABSTRACT Monoclonal antibodies are successful biologics in treating a variety of diseases, including the prevention or treatment of viral infections. CL184 is a 1:1 combination of two human… Expand
  • 20
  • 1